NJ State Employees Deferred Compensation Plan’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,900
| Closed | -$440K | – | 443 |
|
|
2025
Q1 | $440K | Hold |
6,900
| – | – | 0.06% | 303 |
|
|
2024
Q4 | $839K | Hold |
6,900
| – | – | 0.1% | 195 |
|
|
2024
Q3 | $862K | Hold |
6,900
| – | – | 0.1% | 200 |
|
|
2024
Q2 | $1.09M | Hold |
6,900
| – | – | 0.14% | 157 |
|
|
2024
Q1 | $893K | Hold |
6,900
| – | – | 0.11% | 187 |
|
|
2023
Q4 | $665K | Hold |
6,900
| – | – | 0.09% | 230 |
|
|
2023
Q3 | $836K | Hold |
6,900
| – | – | 0.13% | 177 |
|
|
2023
Q2 | $790K | Hold |
6,900
| – | – | 0.11% | 196 |
|
|
2023
Q1 | $951K | Hold |
6,900
| – | – | 0.15% | 164 |
|
|
2022
Q4 | $894K | Hold |
6,900
| – | – | 0.14% | 166 |
|
|
2022
Q3 | $763K | Buy |
+6,900
| New | +$763K | 0.13% | 174 |
|
|
2019
Q3 | – | Sell |
-3,000
| Closed | -$456K | – | 551 |
|
|
2019
Q2 | $456K | Buy |
3,000
+1,000
| +50% | +$152K | 0.08% | 299 |
|
|
2019
Q1 | $238K | Sell |
2,000
-1,000
| -33% | -$119K | 0.04% | 485 |
|
|
2018
Q4 | $327K | Hold |
3,000
| – | – | 0.07% | 348 |
|
|
2018
Q3 | $485K | Buy |
3,000
+1,000
| +50% | +$162K | 0.08% | 330 |
|
|
2018
Q2 | $264K | Buy |
+2,000
| New | +$264K | 0.05% | 446 |
|